| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.77M | $1.38M | $347.76K | $258.73K | $225.60K |
| Cost of Revenue | – | – | – | $146.91K | $96.73K |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.26M | $1.25M | $631.85K | $813.15K | $508.44K |
| R&D | – | – | – | – | – |
| SG&A | $859.08K | $495.81K | $464.06K | $666.24K | $411.72K |
| Operating Income | $500.61K | $133.19K | -$284.09K | -$554.42K | -$282.84K |
| Interest Expense | -$1.31K | $36.27K | $24.81K | $42.07K | $49.11K |
| Tax Expense | – | – | – | – | – |
| Net Income | $494.70K | $73.11K | -$301.38K | -$225.49K | -$322.73K |
| EPS (basic) | – | 0.0000 | -0.0100 | -0.0100 | -0.0100 |
| EPS (diluted) | 0.0100 | 0.0000 | -0.0100 | -0.0100 | -0.0100 |
| Shares (diluted) | – | $37.28M | $36.53M | $35.33M | $32.31M |